Mayo Clinic Network Lead Academic Participating Site

PROJECT SUMMARY Mayo Clinic has a longstanding tradition of clinical research and remains a dedicated supporter of the National Clinical Trials Network (NCTN). This commitment dates to its role in founding the North Central Cancer Treatment Group, now part of the Alliance for Clinical Trials in Oncology. Mayo Clinic continues to provide sustained leadership within the NCTN, with multiple staff holding key roles in NCTN and NCI-sponsored initiatives. Notably, Dr. Evanthia Galanis assumed the role of Group Chair of the Alliance for Clinical Trials in Oncology in 2023. NCTN trials remain a priority within Mayo Clinic’s clinical research portfolio, reflected in high accrual rates, supplemental funding, and refined activation and monitoring strategies. Mayo Clinic physicians actively lead and develop NCTN trials while contributing to national and international scientific discourse through presentations and high-impact publications. Researchers also conduct secondary analyses and leverage biospecimens to advance cancer science. Additionally, Mayo Clinic is committed to fostering the next generation of NCTN investigators, ensuring continued leadership and innovation in clinical research. Our primary goal is to meet the needs of our patients by advancing care through clinical trials.